Advanced search
Publication Cover
Future Medicinal Chemistry Volume 3, 2011 - Issue 2
Submit an article Journal homepage
209
Views
1
CrossRef citations to date
0
Altmetric
Review

GABA Transporters as Targets for New Drugs

Kinga Sałat1 Department of Pharmacodynamics, Jagiellonian University, Medical College, Medyczna 9, 30-688Cracow, PolandView further author information
&
Katarzyna Kulig2 Department of Physicochemical Drug Analysis, Jagiellonian University, Medical College, Medyczna 9, 30–688Cracow, PolandCorrespondence[email protected]
View further author information
Pages 211-222 | Published online: 11 Feb 2011

Bibliography

  • Gajcy K , LochynskiS, LibrowskiT. A role of GABA analogues in the treatment of neurological diseases.Curr. Med. Chem.17, 2338–2347 (2010).
  • Soudijn W , van Wijngaarden I. The GABA transporter and its inhibitors. Curr. Med. Chem.7, 1063–1079 (2000).
  • Czuczwar SJ , PatsalosPN. The new generation of GABA enhancers. Potential in the treatment of epilepsy.CNS Drugs15, 339–350 (2001).
  • Magnaghi V . GABA and neuroactive steroid interactions in glia: new roles for old players?Curr. Neuropharmacol.5, 47–64 (2007).
  • Bowery NG , SmartTG. GABA and glycine as neurotransmitters: a brief history.Br. J. Pharmacol.147, S109–S119 (2006).
  • Jasmin L , WuMV, OharaPT. GABA puts a stop to pain.Curr. Drug Targets CNS Neurol. Disord.3, 487–505 (2004).
  • Sarup A , LarssonOM, SchousboeA. GABA transporters and GABA-transaminase as drug targets.Curr. Drug Targets CNS Neurol. Disord.2, 269–277 (2003).
  • During MJ , RyderKM, SpencerDD. Hippocampal GABA transporter function in temporal lobe epilepsy.Nature376, 174–177 (1995).
  • Handbook of Neurochemistry and Molecular Biology. Neural Membranes and Transport . LajthaA, ReithMEA (Eds). Springer Science+Business Media, LLC (2007).
  • Schousboe A , SarupA, LarssonOM, WhiteHS. GABA transporters as drug targets for modulation of GABAergic activity.Biochem. Pharmacol.68, 1557–1563 (2004).
  • Clausen RP , Fr⊘lundB, LarssonOM, SchousboeA, Krogsgaard-LarsenP, WhiteHS. A novel selective γ-aminobutyric acid transport inhibitor demonstrated a functional role for GABA transporter subtype GAT2/BGT-1 in the CNS.Neurochem. Int.48, 637–642 (2006).
  • Dalby NO , ThomsenCH, Fink-JensenAet al. Anticonvulsant properties of two GABA uptake inhibitors NNC 05–2045 and NNC 05–2090, not acting preferentially on GAT-1. Epilepsy Res. 28, 51–61 (1997).
  • Dalby NO . GABA-level increasing and anticonvulsant effects of three different GABA uptake inhibitors.Neuropharmacology39, 2399–2407 (2000).
  • Meldrum BS , RogawskiMA. Molecular targets for antiepileptic drug development.Neurotherapeutics4, 18–61 (2007).
  • Wu Y , WangW, Diez-SampedroA, RichersonGB. Nonvesicular inhibitory neurotransmission via reversal of the GABA transporter GAT-1.Neuron56, 851–865 (2007).
  • Sadock BJ , SadockVA. Kaplan and Sadock’s Concise Textbook of Clinical Psychiatry. 3rd Edition. WoltersKluwer, Lippincott Williams & Wilkins, PA, USA (2008).
  • Dalby NO . Inhibition of γ-aminobutyric acid uptake: anatomy, physiology and effects against epileptic seizures.Eur. J. Pharmacol.479, 127–137 (2003).
  • Madsen KK , ClausenRP, LarssonOM, Krogsgaard-Larsen, Schousboe A, White HS. Synaptic and extrasynaptic GABA transporters as targets for anti-epileptic drugs. J. Neurochem.109, 139–144 (2009).
  • Thoeringer CK , RipkeS, UnschuldPGet al. The GABA transporter 1 (SLC6A1): a novel candidate gene for anxiety disorders. J. Neural Transm. 116, 649–657 (2009).
  • Chiu CS , BrickleyS, JensenKet al. GABA transporter deficiency causes tremor, ataxia, nervousness, and increased GABA-induced tonic conductance in cerebellum. J. Neurosci. 25, 3234–3245 (2005).
  • Eckstein-Ludwig U , FeiJ, SchwarzW. Inhibition of uptake, steady-state currents and transient charge movements generated by the neuronal GABA transporter by various anticonvulsant drugs.Br. J. Pharmacol.128, 92–102 (1999).
  • Smith CGS , BoweryNG, WhiteheadKJ. GABA transporter type 1 (GAT-1) uptake inhibition reduces stimulated aspartate and glutamate release in the dorsal spinal cord in vivo via different GABAergic mechanisms. Neuropharmacology53, 975–981 (2007).
  • Thomsen CH , SorensenPO, EgebjergJ. 1-(3-(9H-carbazol-9-yl)-1-propyl)-4-(2-methoxyphenyl)-4-piperidinol, a novel subtype selective inhibitor of the mouse type II GABA-transporter.Br. J. Pharmacol.120, 983–985 (1997).
  • Liu GX , CaiGQ, CaiYQet al. Reduced anxiety and depression-like behaviors in mice lacking GABA transporter subtype I. Neuropsychopharmacology 32, 1531–1539 (2007).
  • Hu J , QuickMW. Substrate-mediated regulation of γ-aminobutyric acid transporter 1 in rat brain.Neuropharmacology54, 309–318 (2008).
  • Hull C , LiGL, von Gersdorff H. GABA transporters regulate a standing GABAC receptor-mediated current at a retinal presynaptic terminal. J. Neurosci.26, 6979–6984 (2006).
  • Iversen L . Neurotransmitter transporters and their impact on the development of psychopharmacology.Br. J. Pharmacol.147, S82–88 (2006).
  • Vaz SH , Cristovao-FerreiraS, RibeiroJA, SebastiaoAM. Brain-derived neurotrophic factor inhibits GABA uptake by the rat hippocampal nerve terminals.Brain Res.1219, 19–25 (2008).
  • Iversen LL , KellyJS. Uptake and metabolism of γ-aminobutyric acid by neurons and glial cells.Biochem. Pharmacol.24, 933–938 (1975).
  • Iversen LL , NealMJ. The uptake of [3H] GABA by slices of rat cerebral cortex.J. Neurochem.15, 1141–1149 (1968).
  • Madsen KK , WhiteHS, SchousboeA. Neuronal and non-neuronal GABA transporters as targets for antiepileptic drugs.Pharmacol. Ther.125, 394–401 (2010).
  • Czapinski P , BlaszczykB, CzuczwarSJ. Mechanisms of action of antiepileptic drugs.Curr. Top. Med. Chem.5, 3–14 (2005).
  • Luszczki JJ , SwiaderM, Parada-TurskaJ, CzuczwarSJ. Tiagabine synergistically interacts with gabapentin in the electroconvulsive threshold test in mice.Neuropsychopharmacology28, 1817–1830 (2003).
  • Perucca E . An introduction to antiepileptic drugs.Epilepsia46, 31–37 (2005).
  • Rogawski MA . Molecular targets versus models for new antiepileptic drug discovery.Epilepsy Res.68, 22–28 (2006).
  • Ipponi A , LambertiC, MedicaA, BartoliniA, Malmberg-AielloP. Tiagabine antinociception in rodents depends on GABAB receptor activation: parallel antinociception testing and medial thalamus GABA microdialysis. Eur. J. Pharmacol.368, 205–211 (1999).
  • Laughlin TM , TramKV, WilcoxGL, BirnbaumAK. Comparison of antiepileptic drugs tiagabine, lamotrigine, and gabapentin in mouse models of acute, prolonged and chronic nociception.J. Pharmacol. Exp. Ther.302, 1168–1175 (2002).
  • Luszczki JJ . Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions.Pharmacol. Rep.61, 197–216 (2009).
  • Kvist T , ChristiansenB, JensenAA, Bräuner-OsborneH. The four human γ-aminobutyric acid (GABA) transporters: pharmacological characterization and validation of a highly efficient screening assay.Comb. Chem. High Throughput Screen.12, 241–249 (2009).
  • Borden LA . GABA transporter heterogeneity: pharmacology and cellular localization.Neurochem. Int.29(4), 335–356 (1996).
  • Krogsgaard-Larsen P . γ-aminobutyric acid agonists, antagonists, and uptake inhibitors. Design and therapeutic aspects.J. Med. Chem.24(12), 1377–1383 (1981).
  • Kragel A , HöfnerG, WannerKT. Novel parent structures for inhibitors of the murine GABA transporters mGAT3 and mGAT4.Eur. J. Pharmacol.519(1), 43–47 (2005).
  • Falch E , Krogsgaard-LarsenP. GABA uptake inhibitors. Syntheses and structure–activity studies on GABA analogues containg diarylbutenyl and diarylmethoxyalkyl N-substituents. Eur. J. Med. Chem.26(1), 69–78 (1991).
  • H⊘g S , GreenwoodJR, MadsenKBet al. Structure–activity relationships of selective GABA uptake inhibitors. Curr. Topics Med. Chem. 6, 1861–1882 (2006).
  • Bolving T , LarssonOM, PickeringDSet al. Action of bicyclic isoxazole GABA analogues on GABA transporters and its relation to anticonvulsant activity. Eur. J. Pharmacol. 375, 367–374 (1999).
  • Sarup A , LarssonOM, BolvingT, Fr⊘lundB, Krogsgaard-LarsenP, SchousboeA. Effects of 3-hydroxy-4-amino-4, 5, 6, 7-tetrahydro-1,2-benzisoxazol (exo-THPO) and its N-substituted analogs on GABA transport in cultured neurons and astrocytes and by the four cloned mouse GABA transporters. Neurochem. Inter.43, 445–451 (2003).
  • Falch E , PerregaardJ, Fr⊘lundBet al. Selective inhibitory of glial GABA uptake: synthesis, absolute stereochemistry, and pharmacology of the enantiomers of 3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole (exo-THPO) and analogues. J. Med. Chem. 42, 5402–5414 (1999).
  • White HS , SarupA, BolvigTet al. Correlation between anticonvulsant activity and inhibitory action on glial γ-aminobutyric acid uptake transporter 1 inhibitor 3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole and its N-alkylated analogs. J. Pharmacol. Exp. Ther. 302(2), 636–644 (2002).
  • Clausen RP , MoltzenEK, PerregaardJet al. Selective inhibitors of GABA uptake: synthesis and molecular pharmacology of 4-N-methylamino-4,5,6,7-tetrahydrobenzo[d]isoxazol-3-ol analogues. Bioorg. Med. Chem. 13, 895–908 (2005).
  • Ali FE , BondinellWE, DandridgePAet al. Orally active and potent inhibitors of γ-aminobutyric acid uptake. J. Med. Chem. 28, 653–660 (1985).
  • Andersen KE , BraestrupC, GroenwaldFCet al. The synthesis of novel GABA uptake inhibitors. 1. Elucidation of the structure-activity studies leading tot he choice of (R)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylic acid (tiagabine) as an anticonvulsant drug candidate. J. Med. Chem. 36, 1716–1725 (1993).
  • Bialer M , JohannessenSI, KupferbergHJ, LevyRH, PeruccaE, TomsonT. Progress report on new antiepileptic drugs: a summary of the Eighth Eilat Conference (EILAT VIII)Epilepsy Res.73, 1–52 (2007).
  • Kwan P , SillsGJ, BrodieMJ. The mechanism of action of commonly used drugsPharmacol. Ther.90, 21–34 (2001).
  • Pavia MR , LobbestaelSJ, NugielDet al. Structure–activity studies on benzhydrol-containig nipecotic acid and guvacine derivatives as potent, orally-active inhibitors of GABA uptake. J. Med. Chem. 35, 4238–4248 (1992).
  • Andersen KE , SoerensenJL, LauJet al. Synthesis of novel γ-aminobutyric acid (GABA) uptake inhibitors. 5. Preparation and structure–activity studies of tricyclic analogues of known GABA uptake inhibitors. J. Med. Chem. 44, 2152–2163 (2001).
  • Zhao X , HoeslCE, HoefnerGC, WannerKT. Synthesis and biological evaluation of new GABA-uptake inhibitors derived from proline and from pyrrolidine-2-acetic acid.Eur. J. Med. Chem.40, 231–247 (2005).
  • Fuelep G , HoeslCE, HoefnerG, WannerKT. New highly potent GABA uptake inhibitors selective for GAT-1 and GAT-3 derived from (R)- and (S)-proline and homologous pyrrolidine-2-alkanoic acid. Eur. J. Med. Chem.41, 809–824 (2006).
  • Faust MR , HoefnerG, PabelJ, WannerKT. Azetidine derivatives as novel γ-aminobutyric acid inhibitors: synthesis, biological evaluation, and structure–activity relationship.Eur. J. Med. Chem.45, 2453–2466 (2010).
  • Kragler A , HoefnerG, WannerKT. Synthesis and biological evaluation of aminomethylphenol derivatives as inhibitors of the murine GABA transporters mGAT1-mGAT4.Eur. J. Med. Chem.43, 2404–2411 (2008).
  • Cairrão MAR , RibeiroAM, PizzoABet al. Anticonvulsant and GABA uptake inhibition properties of venom fraction from the spiders Parawixia bistriata and Scaptocasa raptorial. Pharm. Biol. 40, 472–477 (2002).
  • Liberato JL , Siqueira Cunha AO, Mortari MR et al. Anticonvulsant and anxiolytic activity of FrPbAII, a novel GABA uptake inhibitor isolated from the venom of the social spider Parawixia bistriata (Araneidae: Araneae) Brain Res.1124, 19–27 (2006).
  • Schousboe A , LarssonOM, SarupA, WhiteHS. Role of the betaine/GABA transporter (BGT-1/GAT2) for the control of epilepsy.Eur. J. Pharmacol.500, 281–287 (2004).
  • Chroscinska-Krawczyk M , RatnarajN, PatsalosPN, CzuczwarSJ. Effect of caffeine on anticonvulsant effects of oxcarbazepin, lamotrigine and tiagabine in a mouse model of generalized tonic–clonic seizures.Pharmacol. Rep.61, 819–826 (2009).
  • Luszczki JJ , CzuczwarSJ. Isobolographic characterization of interactions between vigabatrin and tiagabine in two experimental models of epilepsy.Prog. Neuropsychopharmacol. Biol. Psychiatry31, 529–538 (2007).
  • Cope DW , Di GiovanniG, FysonSJet al. Enhanced tonic GABAA inhibition in typical absence epilepsy. Nat. Med.15, 1392–1398 (2009).
  • Loescher W , FassbenderCP, NoltingB. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models.Epilepsy Res.8, 79–94 (1991).
  • Dudra-Jastrzebska M , Andres-MachMM, SielskiMet al. Pharmacodynamic and pharmacokinetic interaction profile of levetiracetam in combination with gabapentin, tiagabine and vigabatrin in the mouse pentylenetetrazole-induced seizure model: an isobolographic analysis. Eur. J. Pharmacol. 605, 87–94 (2009).
  • Castelli MP . Multi-faceted aspects of γ-hydroxybutyric acid: a neurotransmitter, therapeutic agent and drug of abuse.Med. Chem.8, 1188–1202 (2008).
  • Luszczki JJ , KolaczA, WojdaE, CzuczwarM, PrzesmyckiK, CzuczwarSJ. Synergistic interaction of gabapentin with tiagabine in the hot-plate test in mice: an isobolographic analysis.Pharmacol. Rep.61, 459–467 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.